414
Participants
Start Date
May 28, 2024
Primary Completion Date
June 19, 2025
Study Completion Date
June 19, 2025
TUTT-PT Intervention
All TUTT-PT arm participants who provide written informed consent will have sputum collected for TB testing (if sputum was not already collected by the clinic staff) and will receive a clinical evaluation for the presence of TB symptoms (cough, fever, weight loss, night sweats) and serious contraindications for TPT initiation (known liver disease, high alcohol intake (men: \>5 drinks/day or \>15 drinks/week; women: \>4 drinks/day or \>8 drinks/week), or strong clinical suspicion of TB disease as evidenced by severity of symptoms, including haemoptysis, or Karnofsky score ≤50. PLHIV for whom the study nurse does not have a strong clinical suspicion of TB nor evidence of serious TPT contraindications will be referred to clinic staff for TPT initiation, irrespective of the presence or absence of TB symptoms.
Perinatal HIV Research Unit, Soweto
University of Witwatersrand, South Africa
OTHER
National Institute of Allergy and Infectious Diseases (NIAID)
NIH
Johns Hopkins University
OTHER